Displaying 1 - 1 of 1
| Active Ingredient | DOXORUBICIN |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Hodgkin's disease, non-Hodgkin's lymphomas, acute leukaemias. |
| Caution | Myelosuppression, reversible, alopecia, nausea, vomiting |
| Dose Range | 60-75mg/M 2 i.v. as a single injection every 3 or 4 weeks; or 1.2-2.4 mg/kg once every 3 weeks. |
| Drug Interactions | |
| Pregnancy | Doxorubicin can cause fetal toxicity when administered to pregnant women, but po More ... |
| Breast Feeding | Not recommended. |